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1. INTRODUCTION
Schiff bases are easily prepared from condensation reaction 
of active carbonyl compounds with primary amines. Variation 
of both the starting aldehyde and the primary amine provides 
a synthetic strategy that readily allows for fine-tuning of the 
physicochemical properties of the Schiff base ligand and hence 
the corresponding metal complexes [1]. The Schiff base deri-
ved from a-amino acid and salicylaldehyde displays excellent 
complexation ability and different mode of coordination to me-
tal ions [2,3]. In recent years, the research about new organo-
tin complexes has been received considerable attention due to 
their structural diversity and biological properties [4-6]. Some 
organotin complexes of the Schiff base derived from salicylal-
dehyde and a-amino acid displayed the monomeric, dimeric, 
trimeric and polymeric structures and significant cytotoxic ac-
tivity against some cancer cells [7-13]. The Schiff base derived 
from salicylaldehyde and L-tyrosine, N-(salicylidene)tyrosine, is 
a multidentate ligand with two hydroxyls, one imine, and one 
carboxyl group. The synthesis, structure and properties of the 
organotin complexes based on this ligand need to be further stu-
died and expanded although several of its diorganotin comple-
xes have been reported [8,12,13]. For this purpose, we synthesi-
zed three diorganotin N-(salicylidene)tyrosinates by the one-pot 
three-component reaction, R2Sn[2-O-3-X-5-YC6H2CH=NCH(-
CH2C6H4OH-4)COO] (R, X, Y = Et, H, H (1); n-Bu, H, Br (2); 
n-Bu, Br, Br (3)), and determined their crystal structures and 
antibacterial activity against Escherichia coli (Scheme 1).
2. EXPERIMENTAL
2.1 Materials and physical measurements
The chemicals were of reagent grade and were used without fur-
ther purification. Carbon, hydrogen and nitrogen analyses were 
obtained using a Perkin Elmer 2400 Series II elemental analyzer. 
The melting points were measured on a WRS-1A digital melting 
point apparatus. IR spectra were recorded on a Nicolet 470 FT-
IR spectrophotometer using KBr discs in the range 4000-400 
cm-1. 1H and 13C NMR spectral data were collected using a 
Bruker Avance III HD 500 MHz NMR spectrometer with CDCl3 
or DMSO-d6 as solvent and TMS as internal standard. 
2.2 Synthesis of the complexes
L-tyrosine (0.362 g, 2 mmol), diorganotin oxide (2 mmol) (for 
Et2SnO 0.386 g, for n-Bu2SnO 0.498 g), and salicylaldehyde 
(0.244 g, 2 mmol) [or 5-bromosalicyaldehyde (0.402 g, 2 mmol) 
or 3,5-dibromosalicyaldehyde (0.560 g, 2 mmol)] were mixed in 
70 mL of anhydrous methanol-chloroform (1:1, V/V). The reac-
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n-Bu2Sn[3,5-Br-2-OC6H2CH=NCH(CH2C6H4OH-4)COO] (3): 
Yield 1.25 g (93%), m.p. 187˚C. Anal. calcd for C
24
H29Br2NO4Sn: 
C 42.77, H 4.34, N 2.08; found C 42.79, H 4.24, N 2.09%. IR 
(KBr): 3387 [n(OH)], 1649 [n(COO)as], 1617 [n(C=N)], 1491, 
1383 [(COO)s], 1367, 1219, 1132, 1025 cm-1. 1H NMR (CDCl3)
d:  0.85 (t, J = 7.5 Hz, 3H, CH3), 0.98 (t, J = 7.5 Hz, 3H, CH3), 
1.25-1.77 (m, 12 H, 2SnCH2CH2CH2), 2.99 (dd, J = 9.0, 14.0 Hz, 
1H, ArCHH), 3.46 (dd, J = 3.5, 14.0 Hz, 1H, ArCHH), 4.18 (dd, 
J = 3.5, 9.0 Hz, 1H, N-CH), 6.15 (s, br., OH), 6.81 (d, J = 8.0 Hz, 
2H, H-3 of C6H4OH), 6.96 (d, J = 8.0 Hz, 2H, H-2 of C6H4OH), 
6.98 (d, J = 2.5 Hz, 1H, H-4 of C6H2Br2), 7.49 (s, J(119Sn-H) = 44 
Hz, 1H, CH=N), 7.83 (d, J = 2.5 Hz, 1H, H-6 of C6H2Br2) ppm. 
13C NMR (CDCl3) d: 173.19 (COO), 170.91 (C=N), 163.61 (C-2 
of C6H2Br2), 155.80 (C-4 of C6H4OH), 141.96 (C-4 of C6H2Br2), 
135.93 (C-6 of C6H2Br2), 131.35 (C-2 of C6H4OH), 126.20 (C-1 
of C6H4OH), 118.24 (C-1 of C6H2Br2), 118.03 (C-3 of C6H2Br2), 
116.21 (C-3 of C6H4OH), 107.45 (C-5 of C6H2Br2), 70.60 (N-C), 
41.19 (ArCH2), 26.92 (C-b), 26.67 (C-b´), 26.66 (C-g), 26.57 
(C-g´), 22.52 ( C-a), 22.19 (C-a´), 13.65 (C-d), 13.48 (C-d´) 
ppm.
2.3 X-ray crystallography
The yellow single crystals of 1-3 was obtained from dichlorome-
thane-methanol (1:1, V/V) by slow evaporation at room tempe-
rature. Diffractions measurements were performed on a Bruker 
Smart Apex imaging-plate area detector fitted with graphite mo-
nochromatized Mo-Ka radiation (0.71073 Å) using the j and w 
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tion mixtures were refluxed under electromagnetic stirring for 
8 h. The yellow solution obtained was cooled and filtered, and 
the solvent was removed under reduced pressure using a rotary 
evaporator. The resulting yellow solid was recrystallized from 
methanol. 
Et2Sn[2-OC6H4CH=NCH(CH2C6H4OH-4)COO] (1): 
Yield 0.80 g (87%), m.p. 222˚C (literature value [13] 225˚C). 1H 
NMR (DMSO-d6) d: 0.98 (t, J = 8.0 Hz, J(119Sn-1H) = 128 Hz, 
3H, CH3), 1.00-1.19 (m, 7H, 2SnCH2+CH3), 2.97 (dd, J = 7.0, 
14.0 Hz, 1H, ArCHH), 3.24 (dd, J = 4.5, 14.0 Hz, 1H, ArCHH), 
4.30 (dd, J = 4.5, 7.5 Hz, 1H, N-CH), 6.63 (d, J = 8.5 Hz, 2H, 
H-3 of C6H4OH),  6.65-6.68 (m, 2H, H-5 and H-6 of C6H4), 7.11 
(dd, J = 2.0, 8.0 Hz, 1H, H-3 of C6H4), 6.89 (d, J = 8.5 Hz, 2H, 
H-2 of C6H4OH), 7.40 (ddd, J = 2.0, 7.5, 8.5 Hz, 1H, H-4 of 
C6H4), 8.19 (s, J(119Sn-1H) = 42 Hz, 1H, CH=N), 9.28 (s, 1H, 
OH) ppm.
n-Bu2Sn[5-Br-2-OC6H3CH=NCH(CH2C6H4OH-4)COO](2):
Yield 1.07 g (90%), m.p. 195˚C ((literature value [13] 193˚C). 
1H NMR (DMSO-d6) d: 0.74 (t, J = 7.5 Hz, 3H, CH3), 0.83 (t, J 
= 7.5 Hz, 3H, CH3), 0.87-0.93 (m, 2H, CH2), 1.15-1.25(m, 6H, 
3CH2), 1.32-1.38 (m, 4H, 2CH2), 3.07 (dd, J = 5.5, 14.0 Hz, 1H, 
ArCHH), 3.20 (dd, J = 5.0, 14.0 Hz, 1H, ArCHH), 4.32 (dd, J = 
5.0, 5.5 Hz,  1H, N-CH), 6.62 (d, J = 9.0 Hz, 1H, H-3 of C6H3Br), 
6.63 (d, J = 8.5 Hz, 2H, H-3 of C6H4OH), 6.84 (d, J = 8.5 Hz, 2H, 
H-2 of C6H4OH), 7.43 (d, J = 2.5 Hz, 1H, H-6 of C6H3Br), 7.48 
(dd, J = 2.5, 9.0 Hz, 1H, H-4 of C6H3Br), 8.40 (s, J(119Sn-1H) = 
45 Hz, 1H, CH=N), 9.28 (s, 1H, OH) ppm.
Table 1. Crystallographic and refinement data of complexes 
Compound 1 2×CH2Cl2 3
Empirical formula C20H23NO4Sn C25H32BrCl2NO4Sn C24H29Br2NO4Sn
Formula weight 460.08 680.02 673.99
Crystal system Orthorhombic Triclinic Monoclinic
Space group Pbca P-1 P21/n
a /Å 14.715(4) 10.851(7) 8.704(2)
b /Å 7.692(2) 11.141(7) 30.117(7)
c /Å 34.902(10) 13.887(9) 10.344(2)
a /(°) 90 70.558(13) 90
b /(°) 90 72.038(12) 102.223(6)
g /(°) 90 68.777(13) 90
Volume /Å3 3950.5(19) 1441.6(16) 2650.0(10)
Z 8 2 4 
Dc / (g×cm
-3) 1.547 1.567 1.689
m / mm-1 1.317 2.487 4.008
F(000) 1856 680 1328
q range /(°) 1.2 to 25.0 2.0 to 25.2 2.1 to 26.0
Crystal size / mm 0.16x0.14x0.01 0.50x0.40x0.30 0.42x0.10x0.08
Tot. reflections 25549 8019 16909
Uniq. Reflections, Rint 3470, 0.109 5066, 0.071 5208, 0.049
R1 indices [I>2s(I)] 0.143 0.080 0.048
wR2 indices (all data) 0.307 0.206 0.118
Dρmin, Dρmax/(e·Å
-3) -0.910, 0.999 -1.734, 1.388 -0.629, 0.770
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scan technique. The structures were solved by direct-methods 
and refined by a full-matrix least squares procedure based on 
F2 using SHELXL-97 [14]. The non-hydrogen atoms were re-
fined anisotropically and hydrogen atoms were placed at calcu-
lated positions in the riding model approximation. In 1, a ethyl 
2.4 Antibacterial activity
The antibacterial activity of the complexes against Escherich-
ia coli was determined by microcalorimetric method according 
to the literature [15]. A 2277 Thermal Activity Monitor (Ther-
mometric AB, Sweden) was used to determine the power-time 
curves of bacterial growth at 310K. The growth rate constants 
(µ) at different concentrations (C) of organotin drugs 1-3 are 
listed in Table 2. The relationship between the growth rate 
constants (µ) and concentration (C) of organotin drug was fit-
ted by using computer, and the linear regression equations for 
1-3 are as follows: μ = -0.00400C+0.06959 (R = 0.98), μ = 
-0.00616C+0.07197 (R = 0.99), and μ = -0.00546C+0.06708 (R 
= 0.96). When the growth rate constant is 0, the minimum inhib-
itory concentration (MIC) was confirmed.
3. RESULTS AND DISCUSSION
Complexes 1-3 were prepared from the one-pot reaction 
of diorganotin oxide, (L)-tyrosine and salicylaldehyde in a 1:1:1 
molar ratio in methanol-chloroform (1:1, v/v) mixed solvent 
with yields of 87-93% (Scheme 1). Compared with the two-step 
method [7-9] in which the Schiff base carboxylic acid ligand 
needs to be first prepared, this preparation process is simpler and 
highly efficient. 
The IR of 3 showed a strong broad band at 3387 cm-1 
assigned to phenolic n(OH) of tyrosyl residue. The differ-
ence between vas(COO) and vs(COO) bands, Dv(COO), is 266 
cm-1, suggesting that the carboxylate is coordinated to tin in a 
monodentate mode [16]. This monodentate coordination mode 
is further confirmed by the shown below X-ray structures. In 1H 
NMR spectra of the complexes, the signal assigned to azome-
thine proton CH=N appear at ~8.3 ppm in DMSO-d6 (1 and 2) 
and 7.49 ppm in CDCl3 (3). The spin-spin coupling between the 
azomethine proton and the tin nucleus, 3J(119Sn-1H), is in the 
range of 42-45 Hz, confirming that there exist the C=N®Sn co-
ordination in the solution in 1-3. The complexes display two sets 
of 1H and 13C NMR signals from the R2Sn (R = Et, Bu) moieties 
indicating that the two R groups experience different environ-
ments on the NMR time scale due to the presence of the rigid 
chelate ring around tin and a stereogenic carbon in the ligand 
[9,17]. The molecular structure of 1-3 is shown in Figures 1-3, 
and selected geometric parameters are given in Table 3. In 1-3, 
the coordination geometry of the tin atom is a distorted trigonal 
(C(3)-C(4)) was disordered over two conformations, the site oc-
cupancies were refined to 0.55(2):0.45(2). In 2 and 3, the site 
occupancies were refined to 0.67(3):0.33(3), 0.60(2):0.40(2), 
and 0.82(2):0.18(2), respectively, for the disorderly butyls. In 
refinements, the C-C bonds and 1,3-distances of the disorderly 
butyl groups were restrained to 1.52(1) and 2.52(2) Å, respec-
tively. The Crystal data, collection procedures and refinement 
results are shown in Table 1. The crystallographic data of 1-3 
have been deposited with the Cambridge Crystallographic Data 
Centre as supplementary publication number CCDC 1588973, 
1964182, and 1964183.
Figure 1.  The molecular structure of 1. Hydrogen atoms are 
omitted for clarity.
Figure 2.  The molecular structure of 2. Only H(4) and H(25A) 
are given for clarity.
Figure 3.  The molecular structure of 3. Hydrogen atoms are 
omitted for clarity.
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bipyramid with two carbons of alkyl groups and a N(1) atom 
from the ligand defining the trigonal plane and a phenolic O(1) 
and a monodentate  carboxylate O(2) atom occupying the axial 
positions. The Sn(1)-O(1) distances (2.067(13)-2.100(6) Å) is 
shorter than Sn(1)-O(2) distances (2.153(14)-2.210(6) Å), and 
the bond angles of the axial positions, O(1)-Sn(1)-O(2), are in 
the range of 157.15(15)°-159.4(5)°. The tin atom forms a five- 
and a six-membered chelate rings with the ONO tridentate li-
gand, and the O(1)-Sn(1)-N(1) (82.47(14)-84.9(5)°) and O(2)-
-Sn(1)-N(1) (74.6(5)-74.8(2)°) angles have a serious deviation 
from the ideal angle of 90°. The monodentate mode of coordi-
nation of carboxylate is also reflected in two disparate C-O bond 
lengths of the carboxylate. For example, in 3, the distances of 
C(17)-O(2) and C(17)-O(3) bonds are 1.287(6) and 1.221(6) Å, 
respectivly.  These structural features are comparable with those 
observed in [3-CH3O-2-OC6H3CH=NCH(CH2Ph)COO]SnEt2 
[18],  [2-O-5-BrC6H3CH=NCH(CH2C6H4OH-4)COO]SnEt2 
[13], [3,5-Br2-2-OC6H2-CH=NCH(CH2Ind)COO]SnBu2 [10], 
and [2-OC6H4CH=NCH(CH(CH3)2)COO]SnCy2 [19].  
In the complexes, there exist the intermolecular O-H⋅⋅⋅O hydro-
Table 2.  Growth rate constants (μ) at different concentrations (C) of 1-3. 
1
C (µg/ml) 0 1.25 2.50 3.75 5.00 6.25
µ (min-1) 0.07053 0.06352 0.05833 0.05566 0.05076 0.04372
2
C (µg/ml) 0 1.25 2.50 3.75 5.00 6.25
µ (min-1) 0.07053 0.06621 0.05536 0.05004 0.04192 0.03230
  3
C (µg/ml) 0 1.25 2.50 3.75 5.00 6.25
µ (min-1) 0.07053 0.05736 0.05116 0.04695 0.04022 0.03386
gen bonds between the phenolic hydroxyl O-H of tyrosyl residue 
and uncoordinated carbonyl O(3) atom from the adjacent ligand 
(Table 4). In 1 and 3, the hydrogen bonds connect the molecules 
into one-dimensional supramolecular chain with Sn×××Sn dis-
tances of 14.292(2) (1) and 10.344(2) Å (3), respectively (Fig-
ure 4). In 2, there is a centrosymmetric R22(20) macrocycle with 
Sn⋅⋅⋅Sn distances of 10.607(2), and the macrocycles are further 
linked by a pair of C(10)-H(10)⋅⋅⋅O(3) hydrogen bonds to form a 
one-dimensional supramolecular chain (Table 4, Figure 5).
The antibacterial activity of the complexes and the reference 
drug (penicillin sodium and cefazolin sodium) was listed in 
Table 5. The results showed that the complexes against Esche-
richia coli are active and more active than the reported  dibu-
tyltin N-(salicylidene)tyrosinate (MIC 20.34 μg⋅mL-1) [13], 
dicyclohexyltin N-(salicylidene)valinate (MIC 23.11 μg⋅mL-1) 
[19], and dibutyltin N-(2-hydroxyl-1-naphthmethylene)glycina-
te (MIC 25 μg⋅mL-1) [20]. They can be considered as anti-bacte-
rial compounds to further study and modified although the acti-
vity of the complexes is lower than that of the reference drugs.
Figure 4. The 1D supramolecular chain in 1 (a) and 3 (b) formed by the O-H⋅⋅⋅O hydrogen bonds. Only hydrogen atoms of hy-
droxyls are given for clarity.
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Figure 5. The R22(20) macrocycle dimer and supramolecular chain in 2 formed by the O-H⋅⋅⋅O and C-H⋅⋅⋅O hydrogen bonds. Only 
one carbon atom of butyl and hydrogen atoms involving hydrogen bonds are given for clarity.
1 2×CH2Cl2
3
Sn(1)-C(1) 
Sn(1)-C(n)
Sn(1)-N(1)
Sn(1)-O(1)
Sn(1)-O(2)
O(1)-Sn(1)-C(1) 
O(1)-Sn(1)-O(2) 
C(1)-Sn(1)-O(2) 
O(1)-Sn(1)-C(n) 
C(1)-Sn(1)-C(n) 
O(2)-Sn(1)-C(n) 
O(1)-Sn(1)-N(1) 
C(1)-Sn(1)-N(1) 
O(2)-Sn(1)-N(1) 
C(n)-Sn(1)-N(1) 
2. 131(19) 
2.15(2)
2.157(12)
2.067(13)
2.153(14)
97.8(6) 
159.4(5) 
92.5(6)
86.7(10)
135.4(12) 
98.1(15) 
84.9(5) 
115.6(7) 
74.6(5) 
109.0(11) 
2.125(10)
2.119(9)
2.174(6) 
2.100(6)
2.210(6)
97.6(4) 
158.7(2)
91.4(4)
92.4(3)
130.8(4)
96.3(3)
83.9(2)
109.2(3)
74.8(2)
119.7(3)
2.117(6)
2.107(7)
2.175(4)
2. 098(4)
2.161(4)
95.4(2)
157.15(15)
95.2(2)
93.7(2)
127.0(3)
96.0(3)
82.47(14)
112.1(2)
74.80(14)
120.9(3)
Table 3. Selected bond lengths (Å) and angles (°) for the complexes.
n = 3 for 1, 5 for 2 and 3
Compound D-H⋅⋅⋅A D-H (Å) H⋅⋅⋅A (Å) D⋅⋅⋅A (Å) D-H⋅⋅⋅A (°) Symmetry codes i
1 O(4)-H(4)⋅⋅⋅O(3)i 0.82 1.87 2.649(2) 159 x-1/2, y, -z+1/2
2×CH2Cl2 O(4)-H(4)⋅⋅⋅O(3)i
C(10)-H(10)⋅⋅⋅O(3)i
C(25)-H(25A)⋅⋅⋅O(2)
0.82
0.98
0.97
1.93
2.40
2.56
2.716(2)
3.323(2)
3.518(2)
160
157
171
-x+1, -y+1, -z
-x+, -y+1, -z
3 O(4)-H(4)⋅⋅⋅O(3)i 0.82 1.92 2.701(1) 159 x, y, z+1
Table 4.  H-Bonding geometry parameters (Å, °) for the complexes
Complex 1 2 3 Penicillin sodium cefazolin sodium
Escherichia coli 17.40 11.68 12.28 8.03 2.01
Table 5.  Antibacterial activity (MIC, μg⋅mL-1) of the complexesa
a MIC = minimum inhibitory concentration.
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